Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders
Trial ID or NCT#
To improve survival outcomes for patients with MDS and MPD with a nonmyeloablative allogeneic hematopoietic cell transplant.
Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Treatment of Myelodysplastic Syndromes and Myeloproliferative Disorders (Except CML)
- - Myelodysplastic Syndromes - Myeloproliferative Disorders - HLA matched donor available
- - organ dysfunction - HIV positive
Contact us to find out if this trial is right for you.